Skip to main content

Predictors of Extrahepatic Recurrence After Curative Hepatectomy for Hepatocellular Carcinoma

Abstract

Background

The aim of this study was to elucidate the predictors of extrahepatic hepatocellular carcinoma (HCC) recurrence after hepatectomy.

Materials and Methods

A cohort of 252 patients with HCC who underwent hepatectomy following a recurrence were reviewed. The patients were categorized into 2 groups according to the pattern of their initial recurrence. Clinicopathological and survival data were compared between the groups.

Results

Of the 252 patients, 218 had intrahepatic recurrence (IHR) (86.5%) and 34 had extrahepatic recurrence (EHR) (13.5%) as their initial recurrence. The mean duration of time until the initial recurrence after hepatectomy of the EHR and IHR groups was 1.8 and 2.2 years, respectively. The rate of recurrence within 6 months after hepatectomy of EHR and IHR groups was 35.3 and 14.2%, respectively (P = .002). The 3-, 5-, and 10-year cumulative survival rates of EHR group were 60.3, 24.0, and 6.0%, respectively, which were significantly lower than that of IHR group (74.5, 57.7, and 23.1%, P = .004). A multivariate analysis showed that blood loss during surgery and microscopic hepatic vein invasion remained as independent risk factors for increased EHR after hepatectomy for HCC. Furthermore, the combination of these 2 independent factors showed a significant association with the EHR.

Conclusions

EHR of HCC was associated with early recurrence and a poor survival after a hepatectomy. The combination of 2 independent factors for EHR, the presence of microscopic hepatic vein invasion and the blood loss during surgery, may be useful for predicting the risk for occurrence of EHR during the follow-up period.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Taketomi A, Kitagawa D, Itoh S, Harimoto N, Yamashita Y, Gion T, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg. 2007;204:580–7.

    Article  PubMed  Google Scholar 

  2. Yamashita Y, Taketomi A, Itoh S, Kitagawa D, Kayashima H, Harimoto N, et al. Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg. 2007;205:19–26.

    Article  PubMed  Google Scholar 

  3. Poon RTP, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10–24.

    Article  Google Scholar 

  4. Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem E, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009;10:1111–8.

    Article  PubMed  Google Scholar 

  5. Taura K, Ikai I, Hatano E, Fujii H, Uyama N, Shimahara Y. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg. 2006;244:265–73.

    Article  PubMed  Google Scholar 

  6. Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg. 2000;191:381–8.

    CAS  Article  PubMed  Google Scholar 

  7. Sakata J, Shirai Y, Wakai T, Kaneko K, Nagahashi M, Hatakeyama K. Preoperative predictors of vascular invasion in hepatocellular carcinoma. Eur J Surg Oncol. 2008;34:900–5.

    CAS  PubMed  Google Scholar 

  8. Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer. 2004;101:796–802.

    Article  PubMed  Google Scholar 

  9. Belghiti J, Regimbeau JM, Durand F, Kianmanesh AR, Dondero F, Terris B, et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology. 2002;49:41–6.

    CAS  PubMed  Google Scholar 

  10. Yang Y, Nagano H, Ota H, Morimoto O, Nakamura M, Wada H, et al. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery. 2007;141:196–202.

    Article  PubMed  Google Scholar 

  11. Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg. 1998;227:80–5.

    CAS  Article  PubMed  Google Scholar 

  12. Choi D, Lim HK, Rhim H, Kim YS, Yoo BC, Paik SW, et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol. 2007;14:2319–29.

    Article  PubMed  Google Scholar 

  13. Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T, et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation. 2009;87:531–7.

    Article  PubMed  Google Scholar 

  14. Tanaka K, Shimada H, Matsuo K, Takeda K, Nagano Y, Togo S. Clinical features of hepatocellular carcinoma developing extrahepatic recurrences after curative resection. World J Surg. 2008;32:1738–47.

    Article  PubMed  Google Scholar 

  15. Utsunomiya T, Shimada M, Shirabe K, Kajiyama K, Gion T, Takenaka K, et al. Clinicopathological characteristics of patients with extrahepatic recurrence following a hepatectomy for hepatocellular carcinoma. Hepatogastroenterology. 2001;48:1088–93.

    CAS  PubMed  Google Scholar 

  16. Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg. 1996;131:71–6.

    CAS  PubMed  Google Scholar 

  17. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1991;214:114–7.

    CAS  Article  PubMed  Google Scholar 

  18. Balsells J, Charco R, Lazaro JL, Murio E, Vargas V, Allende E, et al. Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg. 1996;83:758–61.

    CAS  Article  PubMed  Google Scholar 

  19. Lo CM, Lai EC, Fan ST, Choi TK, Wong J. Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg. 1994;81:1019–21.

    CAS  Article  PubMed  Google Scholar 

  20. Zhou XD, Yu YQ, Tang ZY, Yang BH, Lu JZ, Lin ZY, et al. Surgical treatment of recurrent hepatocellular carcinoma. Hepatogastroenterology. 1993;40:333–6.

    CAS  PubMed  Google Scholar 

  21. Yoon KT, Kim JK, Kimdo Y, Ahn SH, Lee JD, Yun M, et al. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Oncology. 2007;72:104–110.

    Article  PubMed  Google Scholar 

  22. Sun L, Guan YS, Pan WM, Chen GB, Luo ZM, Wu H. Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management. World J Gastroenterol. 2007;13:5413–5.

    PubMed  Google Scholar 

  23. Gion T, Taketomi A, Shimada M, Shirabe K, Hasegawa H, Takenaka K, et al. Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma. Hepatology. 1998;28:1663–8.

    CAS  Article  PubMed  Google Scholar 

  24. Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008;15:1375–82.

    Article  PubMed  Google Scholar 

  25. Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D’Angelica MI, Blumgart LH, Dematteo RP, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009;249:617–23.

    Article  PubMed  Google Scholar 

  26. Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg. 2002;235:217–25.

    Article  PubMed  Google Scholar 

  27. Liu CL, Fan ST, Lo CM, Tso WK, Lam CM, Wong J. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg. 2006;93:1488–94.

    CAS  Article  PubMed  Google Scholar 

  28. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21:327–48.

    Article  PubMed  Google Scholar 

  29. Younes RN, Rogatko A, Vydelingum NA, Brennan MF. Effects of hypovolemia and transfusion on tumor growth in MCA-tumor-bearing rats. Surgery. 1991;109:307–12.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Professor Brian Quinn for his review of this manuscript. This study was supported in part by a grant from the Scientific Research Fund of the Ministry of Education of Japan.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Akinobu Taketomi MD, PhD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Taketomi, A., Toshima, T., Kitagawa, D. et al. Predictors of Extrahepatic Recurrence After Curative Hepatectomy for Hepatocellular Carcinoma. Ann Surg Oncol 17, 2740–2746 (2010). https://doi.org/10.1245/s10434-010-1076-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1076-2

Keywords

  • Extrahepatic Metastasis
  • Portal Vein Invasion
  • Extrahepatic Recurrence
  • Initial Recurrence
  • Bile Duct Invasion